We cured death on a Tuesday,
launched the trial on a Thursday,
by Friday, 14% of the test group
was gnawing on the janitorial staff.
Still, the press was kind.
“Remarkable resilience,” they wrote,
as Unit 42A chewed through its restraints,
and tried to bite a cameraman.
We called them SoulSavers™,
engineered for eternal youth,
a proprietary blend of nanites, CRISPR,
and just a dash of...
Continue reading...